Cargando…
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies
Novel biological agents including cytokines and recombinant fusion proteins are increasingly prescribed for cancer, rheumatologic, autoimmune, and inflammatory diseases, and are currently being evaluated in hepatocellular carcinoma (HCC). They are classified by their mechanism of action and include...
Autores principales: | Hernandez, Nelia, Bessone, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240255/ https://www.ncbi.nlm.nih.gov/pubmed/35836762 http://dx.doi.org/10.14218/JCTH.2021.00243 |
Ejemplares similares
-
Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
por: Bessone, Fernando, et al.
Publicado: (2022) -
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
por: Bessone, Fernando, et al.
Publicado: (2016) -
Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies
por: Frere, Corinne, et al.
Publicado: (2019) -
Current controversies in infective endocarditis
por: Cahill, Thomas J., et al.
Publicado: (2015) -
Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)